Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
  6. News
  7. Summary
    600196   CNE000000X38

SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD.

(600196)
  Report
End-of-day quote Shanghai Stock Exchange  -  2022-09-26
30.45 CNY   +1.20%
09/13China Approves Drug Registration Application for Fosun Pharmaceutical's Anti-Schizophrenia Medication
MT
09/08Neovii and Fosun Pharma Enter into an Exclusive Agreement
AQ
09/08Shandong Liancheng Precision Manufacturing Co., Ltd entered into an agreement to acquire 3.9858% stake in Shanghai Shen-li High Tech Co., Ltd. from Shanghai Fosun Pharmaceutical Co., Ltd. and Shanghai Fulian Technology Co., Ltd. for CNY 61 million.
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Shanghai Fosun Pharmaceutical to Issue New A Shares

07/21/2022 | 04:08am EDT


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
CHINA INTERNATIONAL CAPITAL CORPORATION LIMITED 0.33% 12.08 Delayed Quote.-44.28%
FOSUN INTERNATIONAL LIMITED -2.01% 4.87 Delayed Quote.-43.16%
HKG LIMITED 1.16% 17.45 End-of-day quote.-8.96%
MORGAN STANLEY -0.35% 79.48 Delayed Quote.-19.03%
SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD. 1.20% 30.45 End-of-day quote.-37.78%
UNITED STATES DOLLAR (B) / CHINESE YUAN IN HONG KONG (USD/CNH) 0.76% 7.23131 Delayed Quote.12.81%
All news about SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD.
09/13China Approves Drug Registration Application for Fosun Pharmaceutical's Anti-Schizophre..
MT
09/08Neovii and Fosun Pharma Enter into an Exclusive Agreement
AQ
09/08Shandong Liancheng Precision Manufacturing Co., Ltd entered into an agreement to acquir..
CI
09/06Executive Directors, Senior Management to Acquire More Shares in Shanghai Fosun Pharmac..
MT
09/06Fosun Tourism Group's Shares Fall After Report That Parent Company Is Reducing Stake
DJ
09/04Fosun Pharma Shares Slide After Controlling Shareholder Plans Stake Sale
DJ
08/30Fosun Pharma to Invest $145 Million on New Vaccine Headquarters
MT
08/29Shanghai Fosun Pharma Posts 37% Profit Drop in H1; Revenue Beats Forecast
MT
08/29Shanghai Fosun Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ende..
CI
08/29Shanghai Fosun Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ende..
CI
More news
Financials
Sales 2022 45 085 M 6 282 M 6 282 M
Net income 2022 4 086 M 569 M 569 M
Net Debt 2022 15 069 M 2 100 M 2 100 M
P/E ratio 2022 16,7x
Yield 2022 1,66%
Capitalization 74 243 M 10 345 M 10 345 M
EV / Sales 2022 1,98x
EV / Sales 2023 1,73x
Nbr of Employees 36 604
Free-Float 60,8%
Chart SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD.
Duration : Period :
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 11
Last Close Price 30,45 CNY
Average target price 46,74 CNY
Spread / Average Target 53,5%
EPS Revisions
Managers and Directors
Yu Qing Chen Co-Chief Executive Officer
De Yong Wen Co-Chief Executive Officer & Executive Director
Dong Ming Li Co-President
Shirley Wu General Manager-Finance Management Department
Yi Fang Wu Co-Chairman